테크네튬 99m 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Technetium-99m Market size is expected to reach USD 10.10 Billion in 2034 from USD 7.11 Billion (2025) growing at a CAGR of 3.97% during 2026-2034.

The global technetium-99m market has gained importance in the healthcare sector due to its widespread use in nuclear medicine imaging. Technetium-99m is a radioactive isotope commonly used in diagnostic procedures such as bone scans, cardiac imaging, and cancer detection. Its short half-life and ability to produce clear imaging results make it one of the most widely used isotopes in medical diagnostics.

Several factors are driving the growth of the technetium-99m market. Increasing demand for accurate diagnostic imaging and early disease detection has expanded the use of nuclear medicine technologies. Additionally, advancements in imaging equipment and radiopharmaceutical production have improved the availability and effectiveness of technetium-based diagnostic procedures.

In the coming years, the technetium-99m market is expected to continue growing as healthcare systems prioritize early diagnosis and improved disease management. Research in nuclear medicine and radiopharmaceutical technologies may enhance imaging accuracy and patient safety. Furthermore, expanding healthcare infrastructure in developing regions will likely increase access to nuclear diagnostic procedures.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Clinical Services

• Bone Scan
• Renal Scan
• Cardiac Scan
• Neurology Scan

By Isotopic Application

• Gamma Camera
• Single Photon Emission Computed Tomography (SPECT)

By End User

• Hospitals
• Diagnostic Centers
• Others

COMPANIES PROFILED

• Advanced Accelerator Applications SA, Advanced Cyclotron Systems, Inc, Bayer AG, GE Healthcare, Philips Healthcare,, Siemens Healthineers, Eckert Ziegler, IBA Radiopharma Solutions, MediRadiopharma Kft, Lantheus Holdings, Inc, Nordion, Inc, NTP Radioisotopes SOC Ltd, Jubilant Life Sciences, SDS Lifesciences Pvt Ltd, BWX Technologies, Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL TECHNETIUM-99M MARKET: BY CLINICAL SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Clinical Services
• 4.2. Bone Scan Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Renal Scan Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Cardiac Scan Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Neurology Scan Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL TECHNETIUM-99M MARKET: BY ISOTOPIC APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Isotopic Application
• 5.2. Gamma Camera Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Single Photon Emission Computed Tomography (SPECT) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL TECHNETIUM-99M MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL TECHNETIUM-99M MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Clinical Services
  • 7.2.2 By Isotopic Application
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Clinical Services
  • 7.3.2 By Isotopic Application
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Clinical Services
  • 7.4.2 By Isotopic Application
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Clinical Services
  • 7.5.2 By Isotopic Application
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Clinical Services
  • 7.6.2 By Isotopic Application
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL TECHNETIUM-99M INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Advanced Accelerator Applications S.A
  • 9.2.2 Advanced Cyclotron SystemsInc
  • 9.2.3 Bayer AG
  • 9.2.4 GE Healthcare
  • 9.2.5 Philips Healthcare,
  • 9.2.6 Siemens Healthineers
  • 9.2.7 Eckert & Ziegler
  • 9.2.8 IBA Radiopharma Solutions
  • 9.2.9 Medi-Radiopharma Kft
  • 9.2.10 Lantheus HoldingsInc
  • 9.2.11 NordionInc
  • 9.2.12 NTP Radioisotopes SOC Ltd
  • 9.2.13 Jubilant Life Sciences
  • 9.2.14 SDS Lifesciences Pvt. Ltd
  • 9.2.15 BWX TechnologiesInc